SPIA
RVMD icon

Steward Partners Investment Advisory’s Revolution Medicines RVMD Stock Holding History

Steward Partners Investment Advisory’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$307K Buy
1,640
+909
+124% +$133K ﹤0.01% 1986
2026
Q1 		$71.1K Buy
731
+2
+0.3% +$202 ﹤0.01% 2587
2025
Q4 		$58.1K Sell
729
-50
-6% -$3.28K ﹤0.01% 2595
2025
Q3 		$36.4K Buy
+779
New +$30.5K ﹤0.01% 2764
2025
Q1 		– Sell
-450
Closed -$19.7K – 4139
2024
Q4 		$19.7K Buy
+450
New +$22.7K ﹤0.01% 2807
2021
Q2 		– Sell
-125
Closed -$5.74K – 7350
2021
Q1 		$5.74K Buy
+125
New +$5.61K ﹤0.01% 2980

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Steward Partners Investment Advisory's RVMD Position: Q2 2026 in Review

Steward Partners Investment Advisory increased its Revolution Medicines (RVMD) stake by 124% in Q2 2026, buying an estimated $133K and bringing the position to 1,640 shares worth $307K. The position accounts for ﹤0.01% of the portfolio, ranked #1986.

Steward Partners Investment Advisory first reported a position in RVMD in Q1 2021 and has held it in 6 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Steward Partners Investment Advisory held 1,640 shares of Revolution Medicines worth $307K as of Q2 2026.
  • Steward Partners Investment Advisory bought 909 Revolution Medicines shares in Q2 2026, an estimated $133K.
  • Revolution Medicines made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #1986 holding.
  • Steward Partners Investment Advisory first reported a position in Revolution Medicines in Q1 2021 and has held it in 6 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.